Cialis Blog — Shame on Lilly ICOS
In the Pharma Marketing News article "Blogs and the Pharmaceutical Industry," I made a passing reference to www.cialisblog.com as an example (albeit a BAD...
THE POST MARKETING STUDIES WEEK – Patient Registries
Obtaining real world effectiveness data about products in various patient populations critical for your company's success.
PMNspecialReprints/
Reprints, Supplements, Special Offers: February 2006 The following reprints from recent issues of Pharma Marketing News and Special Supplements are...
Pharma McCarthyism
Despite wishing to be like other industries, pharma is unlike almost every other industry in that its customers are rebelling against it! Pharma is fighting back, which is fine. But let's respect each other, starting with losing the labels that disparage our adversaries.
Hard Sell: The Evolution of a Generation X Salesman
This scathing review of the book 'Hard Sell: The Evolution of a Viagra Salesman,' which is a tell-a-lot-but-not-all about pharmaceutical sales, explores the connection between flagging sales force effectiveness and the generation gap between Boomers and Gen-Xers. 'Dude,' read it!
Branded Physician Education: How to Integrate Promotion and Education
MedPoint Communications, a marketing and educational services company headquartered in Evanston, IL, manages multi-channel, 'within label medical education' programs for its pharmaceutical clients.
What Pharma Companies Spend on Gifts to Docs
At least nine states are considering bills that would require pharmaceutical companies to publicly report annual gifts to physicians, hospitals and pharmacists with California and Vermont in the lead. This report provides numbers of spending limits and average spending by major phramaceutical companies on gifts to physicians in California.
Free Gifts to Physicians: What’s the Big Deal?
Pharma Marketing News hosted an online survey and a Pharma Marketing Expert Roundtable discussion on the topic of pharma gifts to physicians. This article summarizes the findings of that survey and includes comments and insights from survey respondents and Roundtable members.
3rd Annual Pharmaceutical Marketing Compliance Congress
Discover new strategies for balancing risk with promotion when it comes to off-label usage and hear future predictions for DTC advertising regulations.
3rd Annual Phase IV Clinical Trials
Building a well constructed strategic approach to Phase IV studies to meet safety, scientific and regulatory goals with your marketing objectives.
